Immunosuppressant therapy of idiopathic thrombocytopenic purpura.
D000367:Age Factors; D000728:Androgens / Q000627:therapeutic use; D001327:Autoimmune Diseases; D001379:Azathioprine / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D010956:Plasmapheresis; D011696:Purpura, Thrombocytopenic / Q000276:immunology / Q000628:therapy*; D013156:Splenectomy; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000728:Androgens; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D001379:Azathioprine; D003078:Colchicine